The post involves collation and/or collection of clinical data, transcription of clinical trial data into trial specific databases, communication with the study team and study sponsors, developing tools to support protocol specific data-capturing, maintaining study specific files, archive the studies, work with team for study audits, and support study team in meeting data locks. The role requires familiarity with medical terminology and a comprehensive approach to processing trial data and also ability to work under pressure.
Key Requirements
Applications are invited from candidates with a health/science related higher education qualification or relevant experience in clinical trials, who possess excellent organisational skills, strong interpersonal and communication skills and high level of time management skills. The successful candidate will be computer literate and will preferably have previous experience in oncology or clinical trial research or extensive experience in healthcare administration.
Appointments will be on a one-year contract in the first instance. To apply for this post, please submit an online application including a supporting statement, detailing reasons why you are applying for the post and with your CV. We encourage all applicants to access the job pack attached for more detailed information regarding this role.
Due to the high volumes of applications we receive, we reserve the right to close the advert before the published closing date once we have received a sufficient number of applications. Therefore, we advise that you to submit your application, as early as possible to avoid disappointment.
Department/Directorate Information
The Drug Development Unit, (DDU) at The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust, is a world-leading centre for early-phase oncology trials, translating cutting-edge science into first-in-human clinical trials.
Through close integration of laboratory and clinical expertise, the Unit supports the functions of sponsoring early phase trials through Investigator Initiated Trials Team, as well as, delivers academic and industry sponsored trials.
Our mission is to fast-track the development of anti-cancer drugs, designed and synthesised at the Institute of Cancer Research, or developed by CRUK scientists, or developed by industry collaborators, in order to rapidly impact the care of cancer patients. The DDU has been involved in the development of many hundreds of novel agents including several practice-changing cancer drugs.
The DDU is one of the Experimental Cancer Medicine Centres in the UK, part of the CRUK Convergence Science Centre and the Early Phase Drug Development Theme within the ICR-RM NIHR Biomedical Research Centre (BRC). The DDU has multiple academic and industry collaborations both nationally and internationally, to optimally serve our patients. The Unit is led by Professor Johann de Bono and Professor Udai Banerji.